iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News $21.11 +0.11 (+0.52%) (As of 12/7/2023 ET) Add Compare Share Share Today's Range$20.91▼$21.1850-Day Range$17.37▼$21.2952-Week Range$17.33▼$28.06Volume73,700 shsAverage Volume29,063 shsMarket Capitalization$127.72 millionAssets Under Management$120.94 millionDividend Yield0.66%Net Expense Ratio0.47% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings About iShares Genomics Immunology and Healthcare ETFThe iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.Read More IDNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IDNA ETF News HeadlinesNovember 15, 2023 | lse.co.ukIshares Eur Corp Bond Ex-financials 1-5yr Ucits Etf Eur (acc) Share Price (IX5A.AM)November 13, 2023 | lse.co.ukIshares Uk Dividend Ucits Etf Dist Share Price (IUKD.MI)December 8, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 3, 2023 | investing.comIDNA ETF Stock Price HistoryMay 30, 2023 | seekingalpha.comIBDT iShares iBonds Dec 2028 Term Corporate ETFMay 24, 2023 | finance.yahoo.comIDNA - iShares Genomics Immunology and Healthcare ETFMay 10, 2023 | investing.comiShares MSCI Europe Health Care Sector UCITS ETF (ESIH)May 9, 2023 | investing.comiShares STOXX Europe 600 Health Care UCITS (SXDPEX)December 8, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.April 26, 2023 | seekingalpha.comIDNA iShares Genomics Immunology and Healthcare ETFSee More Headlines Receive IDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Genomics Immunology and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IDNA Inception Date6/11/2019 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings58 Fund Statistics Assets Under Management$120.94 million Average Daily Volume$0.00 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest500 shs Miscellaneous Outstanding Shares6,050,000Beta0.90 Creation Unit50,000 Creation Fee$850.00 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report iShares Genomics Immunology and Healthcare ETF ExpensesTypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.53%0.50%0.51%Other Expenses0.00%0.76%0.54%0.64%0.57%Total Expense0.47%0.73%0.70%0.73%0.70%Fee Waiver0.00%-0.78%-0.54%-0.69%-0.57%Net Expense0.47%0.60%0.60%0.57%0.57% iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings & ExposureTop 10 IDNA HoldingsExelixis(NASDAQ:EXEL)Holding Weight: 4.79%Ginkgo Bioworks(NYSE:DNA)Holding Weight: 4.69%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 4.66%SANOFI SAHolding Weight: 4.60%BioNTech(NASDAQ:BNTX)Holding Weight: 4.24%GENMABHolding Weight: 4.22%TAKEDA PHARMACEUTICAL LTDHolding Weight: 4.19%ROCHE HOLDING PAR AGHolding Weight: 4.11%BEIGENE LTDHolding Weight: 3.86%SpringWorks Therapeutics(NASDAQ:SWTX)Holding Weight: 3.78%IDNA Sector ExposureIDNA Industry ExposureFull Holdings Details Similar ETFsAvantis Responsible International Equity ETFNYSEARCA:AVSDETFMG U.S. Alternative Harvest ETFNYSEARCA:MJUSKnowledge Leaders Developed World ETFNYSEARCA:KLDWAXS Change Finance ESG ETFNYSEARCA:CHGXHumankind US Stock ETFNYSEARCA:HKNDInstitutional OwnershipAmeriprise Financial Inc.Bought 8,644 shares on 11/15/2023Ownership: 1.633%Integrated Wealth Concepts LLCSold 9,770 shares on 11/15/2023Ownership: 0.940%RiverFront Investment Group LLCSold 1,408 shares on 11/7/2023Ownership: 0.678%View All Institutional Transactions IDNA ETF - Frequently Asked Questions How have IDNA shares performed in 2023? iShares Genomics Immunology and Healthcare ETF's stock was trading at $25.17 at the beginning of the year. Since then, IDNA shares have decreased by 16.1% and is now trading at $21.11. View the best growth stocks for 2023 here. What does IDNA invest in? iShares Genomics Immunology and Healthcare ETF is a equity fund issued by iShares. IDNA focuses on theme investments and follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund's investments total to approximately $120.94 million assets under management. What stocks does iShares Genomics Immunology and Healthcare ETF hold? IDNA invests in 58 holdings. Some of the stocks in their portfolio include Exelixis (EXEL), Ginkgo Bioworks (DNA), Regeneron Pharmaceuticals (REGN), BioNTech (BNTX), SpringWorks Therapeutics (SWTX), Blueprint Medicines (BPMC), BioCryst Pharmaceuticals (BCRX), Twist Bioscience (TWST), Iovance Biotherapeutics (IOVA) and Moderna (MRNA). What is the management fee for iShares Genomics Immunology and Healthcare ETF? iShares Genomics Immunology and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IDNA is 0.47%. What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY). Who are iShares Genomics Immunology and Healthcare ETF's major shareholders? iShares Genomics Immunology and Healthcare ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Ameriprise Financial Inc. (1.63%), Integrated Wealth Concepts LLC (0.94%) and RiverFront Investment Group LLC (0.68%). How do I buy shares of iShares Genomics Immunology and Healthcare ETF? Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSEARCA:IDNA) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.